When specifically inhibiting the CKLF1/CCR4 axis, the activation of NLRP3 and the subsequent inflammatory response process could be further inhibited, thus protecting neurological function and improving cerebral ischemia (Ai et al., 2019). Here, NLRP3 is linked to Cerebral ischemia.